The results presented here provide evidence that modulation of miR-145/GSDMD is closely involved in the anticancer activity of tanshinone II A on HeLa cells, which provides a strong evidence to support that tanshinone II A can act as a potential anticancer drug against cervical cancer. Here, GSDMD is linked to cervical carcinoma.